Continuing Education

Understanding current and emerging therapies for HNC

Understanding current and emerging therapies for HNC

Head and neck cancer treatments have high morbidity rates. Newer options reduce morbidities and offer patients better quality of life after treatment.

Vertebroplasty is effective for managing myelomatous VCFs

Vertebroplasty is effective for managing myelomatous VCFs

The minimally invasive procedure provides effective, immediate relief from the pain of vertebral compression fractures due to multiple myeloma.

Lung cancer: Guidelines, new drugs improve outcomes

Lung cancer: Guidelines, new drugs improve outcomes

Advances in treatments, better risk assessment, and effective supportive care are leading to better outcomes for patients with lung cancer.

Pain management in patients receiving palliative care

Pain management in patients receiving palliative care

Understanding pain mechanisms and the types, triggers, and alleviating factors is needed to provide effective analgesia for patients with cancer.

Non-small cell lung cancer: Molecular targets and 
emerging options for care

Non-small cell lung cancer: Molecular targets and 
emerging options for care

This activity from myCME offers a review of groundbreaking molecular research and novel treatment options for patients with NSCLC.

Managing chemotherapy side effects: Tumor lysis syndrome

Managing chemotherapy side effects: Tumor lysis syndrome

Patients undergoing chemotherapy for hematologic cancers are at risk for this complication. The review can help you learn how to assess their risk.

Meeting the billing challenges inherent with clinical trials

Meeting the billing challenges inherent with clinical trials

A primer on what nurses need to know when scheduling items and services for patients participating in clinical trials.

Understanding the impact of disparities on cancer care

Understanding the impact of disparities on cancer care

Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.

GVHD in pediatric HSCT patients: Clinical trials for Rituximab

GVHD in pediatric HSCT patients: Clinical trials for Rituximab

The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.

Using anticoagulants to treat chemotherapy-related VTE

Using anticoagulants to treat chemotherapy-related VTE

Signs and symptoms of venous thromboembolism in oncology patients should be heeded with prompt therapeutic and mechanical interventions.

Primary-care prevention of cervical cancer

Primary-care prevention of cervical cancer. To reduce the mortality and incidence of this disease, clinicians must be aware of the most recent vaccination and screening guidelines.

More Oncology Activities from myCME.com

myCME.com offers over 50 oncology activities. Click here to view them all.

Sign Up for Free e-newsletters

April Contest: Win a Pebble Watch

Start the contest today

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs